From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN ...

Technological advances, clinical demand, and comprehensive tumor cell analysis are driving growth in the circulating tumor cell detection market, offering opportunities in diagnostics and clinical ...

Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically meaningful 3D models—faster, more consistently, and with full traceability. Yet ...

A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s ...

Dr. William Chen discusses NAMs, AI, and the future of risk assessment for cell-based foods With cultivated meat emerging as one of the most promising innovations in alternative proteins, regulators ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

BioLife Solutions has executed a successful turnaround by refocusing on core products and divesting non-core assets. Read ...

KACTUS, a biotechnology company located in Waltham, Massachusetts, has made commercially available ultra-low endotoxin recombinant human kallikrein-1 (KLK1) ...

One of the hardest things to do when you establish an experiment that requires the measurement of proteins, cytokines, or biomarkers is the selection of the appropriate assay kit. Product catalogs are ...

This GEN eBook examines how ddPCR technology is applied in practice through case studies highlighting its analytical strengths over traditional qPCR.

A cube of healthy bone is anything but solid. Inside it, countless tiny channels carry fluid and help cells move, feed, and ...